Clinical Trial Update: Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

View source ↗

Summary

ClinicalTrials.gov update describing the clinical and demographic characteristics of adults with Neurofibromatosis in Russia, sponsored by AstraZeneca, with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis

Snippet

Sponsor: AstraZeneca | Conditions: Neurofibromatosis | Status: RECRUITING